At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 100 enrolled
Drug / intervention
IMRTradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Intensity Modulated Radiation Therapy for Breast Cancer: A Phase I Feasibility Study
In Brief
A Phase 1 clinical trial evaluating IMRT for Breast Cancer. Completed, enrolled 100 participants across 1 site.
Detailed Summary
This study delivers radiation therapy to any residual breast tissue and the chest wall plus lymph node areas around the breast. These lymph node areas are under the arm, around the collar bone, and under the sternum (breastbone).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2008
First PostedJan 2008
Primary CompletionAug 2016
TodayJul 2026
First PostedJan 15, 2008
Enrollment StartJan 4, 2008
Primary CompletionAug 8, 2016
TodayJul 2, 2026
Enrollment to primary: 8.6 yearsPosted 18.5 years ago
Interventions
IMRTradiation